Roivant Sciences Ltd. (ROIV) Misses Q1 EPS by 10c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q1 EPS of ($0.38), $0.10 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $21.62 million versus the consensus estimate of $24.77 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Creatd files Form S-1 and reports Q1 2026 financial results
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen